Therapeutic potential of complement modulation.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Works matching IS 14741776 AND DT 2010 AND VI 9 AND IP 1
Results: 26
1
2
Adding calorimetric data to decision making in lead discovery: a hot tip.
- Published in:
- 2010
- By:
- Publication type:
- review
3
Subcellular targeting strategies for drug design and delivery.
- Published in:
- 2010
- By:
- Publication type:
- journal article
4
Key factors in the discovery and development of new antiepileptic drugs.
- Published in:
- 2010
- By:
- Publication type:
- journal article
5
Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application.
- Published in:
- 2010
- By:
- Publication type:
- journal article
6
Proteases: Unravelling the therapeutic activity of activated protein C.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 1, p. 20, doi. 10.1038/nrd3082
- By:
- Publication type:
- Article
7
Respiratory syncytial virus market.
- Published in:
- 2010
- By:
- Publication type:
- journal article
8
Patent watch.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 1, p. 12, doi. 10.1038/nrd3077
- Publication type:
- Article
9
Biotechnology: Hanging around for longer.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 1, p. 20, doi. 10.1038/nrd3080
- By:
- Publication type:
- Article
10
Antiviral drugs: Adenosine analogue blocks dengue infection.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 1, p. 21, doi. 10.1038/nrd3081
- By:
- Publication type:
- Article
11
Pazopanib.
- Published in:
- 2010
- By:
- Publication type:
- journal article
12
Autoimmunity: Targeted T<sub>Regs</sub> tame autoimmune disease.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 1, p. 19, doi. 10.1038/nrd3083
- By:
- Publication type:
- Article
13
Neurodegenerative disease: Synergistic destruction.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 1, p. 22, doi. 10.1038/nrd3084
- By:
- Publication type:
- Article
14
News in brief.
- Published in:
- 2010
- Publication type:
- Abstract
15
2009 in reflection.
- Published in:
- 2010
- By:
- Publication type:
- journal article
16
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 1, p. 9, doi. 10.1038/nrd3088
- Publication type:
- Article
17
Stem cell-based therapeutics.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 1, p. 83, doi. 10.1038/nrd3089
- Publication type:
- Article
18
Marc Cluzel.
- Published in:
- 2010
- By:
- Publication type:
- Interview
19
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 1, p. 1, doi. 10.1038/nrd3091
- Publication type:
- Article
20
Assessing the risks of risk sharing.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 1, p. 3, doi. 10.1038/nrd3092
- Publication type:
- Article
21
Trial watch: Antisense agent reduces LDL–cholesterol levels in high-risk patients.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 1, p. 10, doi. 10.1038/nrd3093
- Publication type:
- Article
22
Deal watch : BMS acquires rights for IL-6 inhibitor.
- Published in:
- 2010
- Publication type:
- journal article
23
Market watch: Upcoming market catalysts in Q1 of 2010.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 1, p. 11, doi. 10.1038/nrd3095
- By:
- Publication type:
- Article
24
Market watch: Upcoming market catalysts in Q4 2009.
- Published in:
- 2010
- By:
- Publication type:
- Correction Notice
25
Orphan products: an emerging trend in drug approvals.
- Published in:
- 2010
- By:
- Publication type:
- Letter
26
Broadening access to electronic healthcare databases.
- Published in:
- 2010
- By:
- Publication type:
- Letter